Shuai Zhen

1.6k total citations
35 papers, 1.2k citations indexed

About

Shuai Zhen is a scholar working on Molecular Biology, Epidemiology and Oncology. According to data from OpenAlex, Shuai Zhen has authored 35 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Molecular Biology, 10 papers in Epidemiology and 6 papers in Oncology. Recurrent topics in Shuai Zhen's work include CRISPR and Genetic Engineering (11 papers), RNA Interference and Gene Delivery (5 papers) and Virus-based gene therapy research (4 papers). Shuai Zhen is often cited by papers focused on CRISPR and Genetic Engineering (11 papers), RNA Interference and Gene Delivery (5 papers) and Virus-based gene therapy research (4 papers). Shuai Zhen collaborates with scholars based in China, Japan and Pakistan. Shuai Zhen's co-authors include Jiaojiao Lu, Yōichirō Takahashi, Xu Li, Hua Ling, Le Zhao, Yan Li, Yunhui Liu, Xu Li, Yuanfeng Pang and Xiaomin Sun and has published in prestigious journals such as PLoS ONE, Chemical Engineering Journal and Biochemical and Biophysical Research Communications.

In The Last Decade

Shuai Zhen

32 papers receiving 1.2k citations

Peers

Shuai Zhen
Guigao Lin China
Masakazu Hamada Japan
Sang-Jin Lee South Korea
Jochen Decker Germany
Richard H. Tullis United States
Jinfeng Huang China
Dmitry Kostyushev Russia
Midori Mitui United States
Guigao Lin China
Shuai Zhen
Citations per year, relative to Shuai Zhen Shuai Zhen (= 1×) peers Guigao Lin

Countries citing papers authored by Shuai Zhen

Since Specialization
Citations

This map shows the geographic impact of Shuai Zhen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shuai Zhen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shuai Zhen more than expected).

Fields of papers citing papers by Shuai Zhen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Shuai Zhen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shuai Zhen. The network helps show where Shuai Zhen may publish in the future.

Co-authorship network of co-authors of Shuai Zhen

This figure shows the co-authorship network connecting the top 25 collaborators of Shuai Zhen. A scholar is included among the top collaborators of Shuai Zhen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shuai Zhen. Shuai Zhen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Zhen, Shuai, Jianguo Zhang, Abubakar Dar, et al.. (2024). Orange peel biochar: An effective amendment to improve the maize resilience by regulating the soil enzymatic activities, nutrient uptake, and ionic homeostasis under salinity stress. Industrial Crops and Products. 222. 120081–120081. 12 indexed citations
2.
Xu, Jianbo, et al.. (2023). Association between postoperative thrombocytopenia and outcomes after traumatic brain injury surgery: A cohort study. Acta Anaesthesiologica Scandinavica. 67(7). 918–924.
3.
Xu, Jianbo, et al.. (2023). Obesity is associated with postoperative outcomes in patients undergoing cardiac surgery: a cohort study. BMC Anesthesiology. 23(1). 3–3. 8 indexed citations
4.
Zhen, Shuai, et al.. (2023). CRISPR/Cas9 for hepatitis B virus infection treatment. Immunity Inflammation and Disease. 11(5). e866–e866. 8 indexed citations
5.
Zhen, Shuai, et al.. (2022). CRISPR/Cas9‐HPV‐liposome enhances antitumor immunity and treatment of HPV infection‐associated cervical cancer. Journal of Medical Virology. 95(1). e28144–e28144. 28 indexed citations
6.
Zhu, Yanhong, et al.. (2022). Mechanical power of ventilation is associated with mortality in neurocritical patients: a cohort study. Journal of Clinical Monitoring and Computing. 36(6). 1621–1628. 15 indexed citations
7.
Cai, Bo, et al.. (2021). The genotype and phenotype of chromosome 18p deletion syndrome. Medicine. 100(18). e25777–e25777. 7 indexed citations
8.
Zhen, Shuai, Yan Liu, Jiaojiao Lu, et al.. (2020). Human Papillomavirus Oncogene Manipulation Using Clustered Regularly Interspersed Short Palindromic Repeats/Cas9 Delivered by pH-Sensitive Cationic Liposomes. Human Gene Therapy. 31(5-6). 309–324. 48 indexed citations
9.
10.
Zhen, Shuai, et al.. (2019). Synergistic antitumor effect on cervical cancer by rational combination of PD1 blockade and CRISPR-Cas9-mediated HPV knockout. Cancer Gene Therapy. 27(3-4). 168–178. 48 indexed citations
11.
Zhen, Shuai & Xu Li. (2018). Application of CRISPR-Cas9 for Long Noncoding RNA Genes in Cancer Research. Human Gene Therapy. 30(1). 3–9. 32 indexed citations
12.
Lu, Jiaojiao, Lijie Wang, Wei Chen, et al.. (2018). miR-603 targeted hexokinase-2 to inhibit the malignancy of ovarian cancer cells. Archives of Biochemistry and Biophysics. 661. 1–9. 43 indexed citations
13.
Han, Xi, Shuai Zhen, Jiaojiao Lu, et al.. (2017). A Feedback Loop Between miR-30a/c-5p and DNMT1 Mediates Cisplatin Resistance in Ovarian Cancer Cells. Cellular Physiology and Biochemistry. 41(3). 973–986. 71 indexed citations
14.
Zhen, Shuai & Xu Li. (2017). Oncogenic Human Papillomavirus: Application of CRISPR/Cas9 Therapeutic Strategies for Cervical Cancer. Cellular Physiology and Biochemistry. 44(6). 2455–2466. 33 indexed citations
15.
Zhen, Shuai, Jiaojiao Lu, Lijie Wang, et al.. (2016). In Vitro and In Vivo Synergistic Therapeutic Effect of Cisplatin with Human Papillomavirus16 E6/E7 CRISPR/Cas9 on Cervical Cancer Cell Line. Translational Oncology. 9(6). 498–504. 80 indexed citations
16.
Zhou, Yuanyuan, Ke Wang, Shuai Zhen, Ruili Wang, & Wenjuan Luo. (2016). Carfilzomib induces G2/M cell cycle arrest in human endometrial cancer cells via upregulation of p21Waf1/Cip1 and p27Kip1. Taiwanese Journal of Obstetrics and Gynecology. 55(6). 847–851. 14 indexed citations
17.
Hua, Ling, et al.. (2014). Expression and biochemical characterization of recombinant human epididymis protein 4. Protein Expression and Purification. 102. 52–62. 27 indexed citations
18.
Cheng, Ge, et al.. (2014). CYP1A1 polymorphism interactions with smoking status in oral cancer risk: evidence from epidemiological studies. Tumor Biology. 35(11). 11183–11191. 9 indexed citations
19.
Zhen, Shuai, et al.. (2014). In vitro and in vivo growth suppression of human papillomavirus 16-positive cervical cancer cells by CRISPR/Cas9. Biochemical and Biophysical Research Communications. 450(4). 1422–1426. 176 indexed citations
20.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Guigao Lin Breakdown of academic impact, for papers by Masakazu Hamada Breakdown of academic impact, for papers by Sang-Jin Lee Breakdown of academic impact, for papers by Jochen Decker Breakdown of academic impact, for papers by Richard H. Tullis Breakdown of academic impact, for papers by Jinfeng Huang Breakdown of academic impact, for papers by Dmitry Kostyushev Breakdown of academic impact, for papers by Midori Mitui
Rankless by CCL
2026